Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma, Ewing × Diphosphonates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Sarcoma, Ewing 1 Neoplasms 1 Multiple Myeloma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 10 Irinotecan 8 Melphalan 7 Vincristine 6 Temozolomide 6 Doxorubicin 6 Busulfan 6 Topotecan 5 Granulocyte Colony-Stimulating Factor 5 Ifosfamide 4 Gemcitabine 4 Filgrastim 4 Etoposide 4 Trabectedin 3 Sirolimus 3 Nivolumab 3 Albumin-Bound Paclitaxel 3 pegfilgrastim 2 olaparib 2 fludarabine phosphate 2 fludarabine 2 eribulin 2 cixutumumab 2 abemaciclib 2 X-Rays 2 Radiotherapy, Intensity-Modulated 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 FANG vaccine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡